# BEPACT- Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in Belgium

> **NCT03959137** · — · COMPLETED · sponsor: **MSD Belgium BVBA** · enrollment: 215 (actual)

## Conditions studied

- Stage IV Non-small Cell Lung Cancer

## Interventions

- **OTHER:** None - Common practice

## Key facts

- **NCT ID:** NCT03959137
- **Lead sponsor:** MSD Belgium BVBA
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-03
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 215 (ACTUAL)
- **Last updated:** 2021-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03959137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03959137, "BEPACT- Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in Belgium". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03959137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*